Rapamycin treatment of progeria cells lowered the levels of progerin and wild‐type prelamin A. It could also increase the relative expression of ZMPSTE24, which is a prelamin A endoprotease. This evidence concerns the gene ZMPSTE24 and progeroid syndrome.